Vistagen Therapeutics, Inc. Common Stock
Symbol: VTGN (NASDAQ)
0.00
▼ (-100.00%) -2.060
Company Description:
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $2.06
- Yesterday High: $2.3533
- Yesterday Low: $2.05
- Yesterday Volume: 427.75K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Vistagen Therapeutics, Inc. Common Stock
- Website: https://www.vistagen.com
- Listed Date: 2009-07-01
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001411685
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $66.82M
- Round Lot: 100
- Outstanding Shares: 28.86M
- Asset Type: CS
RECENT FILINGS FOR VTGN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-06-17 | 8-K | View |
| 2025-06-17 | 424B5 | View |
| 2025-06-17 | 10-K | View |
| 2025-06-02 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-03-06 | 8-K | View |
| 2025-02-14 | SCHEDULE 13G/A | View |
| 2025-02-14 | SCHEDULE 13G/A | View |
| 2025-02-14 | SCHEDULE 13G/A | View |
| 2025-02-13 | 10-Q | View |
| 2025-02-13 | 8-K | View |
| 2025-02-05 | 8-K | View |
| 2025-01-14 | 8-K | View |
| 2025-01-13 | 4 | View |
| 2025-01-13 | 4 | View |
| 2025-01-13 | 8-K | View |
| 2024-12-06 | 8-K | View |
| 2024-11-14 | SC 13G/A | View |
| 2024-11-14 | SCHEDULE 13G/A | View |
| 2024-11-14 | SC 13G/A | View |
Latest News on VTGN